The University at Buffalo is strengthening education for medical residents who care for patients who are addicted or are at risk for addiction by focusing more training on safe prescribing practices and safe pain management.
Ralph H. Benedict, PhD, professor in the Department of Neurology, has been named the 2016 recipient of the International Neuropsychological Society (INS) Mid-Career Award.
Clinical trials conducted by Arie L. Weinstock, MD, clinical professor of neurology, are exploring the safety and effectiveness of medical marijuana treatments for epilepsy patients.
Stephanie Anzman-Frasca, PhD, assistant professor in the Department of Pediatrics, has authored new research showing that revising children’s restaurant menus successfully encourages long-term healthier eating habits.
Zhen Yan, PhD, professor in the Department of Physiology and Biophysics, has been awarded a three-year, $540,000 private foundation grant for her work on novel therapeutic strategies for autism.
John J. Leddy, MD, clinical professor in the Department of Orthopaedics, is conducting a study emphasizing moderate exercise that may dramatically alter the standard of care for acute concussion.
A study led by Paresh Dandona, MD, PhD, has demonstrated that men with Type 2 diabetes who have low testosterone levels can benefit significantly from testosterone treatment.
A team of investigators led by Jian Feng, PhD, professor in the Department of Physiology and Biophysics, has developed a new way to ramp up the conversion of skin cells into dopamine neurons — research that could help patients with Parkinson’s disease.
Jeffrey M. Lackner, PsyD, is leading a pilot study to determine whether behavioral self-management of irritable bowel syndrome (IBS) may lead to fundamental changes in the digestive system’s bacterial ecosystem.
The Genome, Environment and Microbiome (GEM) community — part of a University at Buffalo initiative that seeks new approaches to global challenges — has had its inaugural meeting.
Stanley F. Fernandez, MD, PhD, research assistant professor of medicine, says the new statin alternatives known as PCSK9 inhibitors are a welcome treatment for high cholesterol.
Beth A. Smith, MD, clinical associate professor of psychiatry, has helped develop international guidelines for the screening and treatment of depression and anxiety in people with cystic fibrosis.
Caressa Chen and Warren Tai — who have spent the past several months conducting intensive research in prestigious biomedical laboratories — were two of only 14 students nationwide selected as 2015-16 Sarnoff Fellows.
Only a quarter of headache clinical trials published in the field’s core journals over a nine-year period were registered in an approved clinical trial registry, according to a study led by Melissa Rayhill, MD, and published in Neurology.
Michael W. Russell, PhD, has co-edited and co-written the fourth edition of the only comprehensive reference on mucosal immunology’s basic science and clinical manifestations.
Amy Jacobs, PhD, assistant professor of microbiology and immunology, received an award from the National Science Foundation to focus on the entry mechanism of the Ebola virus. The mechanism could be used to deliver drugs to infected cells.
Kara Kelly, MD ’89, has been appointed chief of the Division of Hematology and Oncology in the Department of Pediatrics, and she will lead the joint pediatric hematology and oncology program.
Research by a biochemistry doctoral candidate is featured on the cover of the Journal of Neurochemistry for its potential to contribute to the treatment of neurodegenerative disorders.
Researchers at the Hunter James Kelly Research Institute (HJKRI) have discovered a new way to study the interface where cells in the myelination process touch — a method that may lead to a better understanding of myelin diseases.
The Myasthenia Gravis Foundation of America (MGFA) has awarded Gil. I Wolfe, MD, professor and Irvin and Rosemary Chair of Neurology, with the 2015 Doctor of the Year Award.
